Paper Details 
Original Abstract of the Article :
OBJECTIVES: To compare the efficacy of formoterol, montelukast and acebrophylline when used in combination with budesonide in patients with bronchial asthma and to determine their role in the improvement of the quality of life of patients. MATERIALS AND METHODS: A total of 75 patients were divided ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225908/

データ提供:米国国立医学図書館(NLM)

Comparing Asthma Medications: Finding the Right Fit in a Sea of Choices

The world of asthma treatment is a vast and diverse landscape, with numerous medications available to manage this chronic condition. This study delves into the comparative efficacy of three classes of drugs: formoterol, montelukast, and acebrophylline, when combined with budesonide. The research utilized a prospective study to assess the effectiveness of these drug combinations in improving lung function and quality of life in patients with bronchial asthma. The findings provide valuable insights into the relative benefits of different asthma treatments, guiding clinicians in choosing the most appropriate approach for each patient.

Navigating the Asthma Treatment Landscape

The study demonstrates that all three drug combinations - formoterol, montelukast, and acebrophylline, when combined with budesonide - were effective in improving lung function and quality of life in patients with bronchial asthma. However, the study also highlights the importance of individualizing treatment, as some patients may experience adverse effects. The study's results emphasize the need to carefully consider the patient's overall health and individual needs when selecting an asthma treatment.

Navigating the Asthma Treatment Landscape

The study demonstrates that all three drug combinations - formoterol, montelukast, and acebrophylline, when combined with budesonide - were effective in improving lung function and quality of life in patients with bronchial asthma. However, the study also highlights the importance of individualizing treatment, as some patients may experience adverse effects. The study's results emphasize the need to carefully consider the patient's overall health and individual needs when selecting an asthma treatment.

Dr. Camel's Conclusion

Just as a camel must choose the most suitable path through a vast and diverse desert, patients with asthma need to find the right treatment to manage their condition effectively. This study provides valuable insights into the comparative efficacy of different asthma medications, reminding us that the best approach is often one that is tailored to the individual needs of each patient.

Date :
  1. Date Completed 2014-11-11
  2. Date Revised 2020-10-01
Further Info :

Pubmed ID

25386456

DOI: Digital Object Identifier

PMC4225908

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.